Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.
Leon Medical Centers, in partnership with Johns Hopkins Medicine’s Brady Urological Institute and Florida International University’s Herbert Wertheim College of Medicine, hosted<a class="excerpt-read- ...